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Abstract
Major depressive disorder (MDD) is a common mood disorder. Gut microbiota may be involved in the pathogenesis of
depression via the microbe–gut–brain axis. Liver is vulnerable to exposure of bacterial products translocated from the
gut via the portal vein and may be involved in the axis. In this study, germ-free mice underwent fecal microbiota
transplantation from MDD patients and healthy controls. Behavioral tests verified the depression model. Metabolomics
using gas chromatography–mass spectrometry, nuclear magnetic resonance, and liquid chromatography–mass
spectrometry determined the influence of microbes on liver metabolism. With multivariate statistical analysis, 191
metabolites were distinguishable in MDD mice from control (CON) mice. Compared with CON mice, MDD mice
showed lower levels for 106 metabolites and higher levels for 85 metabolites. These metabolites are associated with
lipid and energy metabolism and oxidative stress. Combined analyses of significantly changed proteins in livers from
another depression model induced by chronic unpredictive mild stress returned a high score for the Lipid Metabolism,
Free Radical Scavenging, and Molecule Transports network, and canonical pathways were involved in energy
metabolism and tryptophan degradation. The two mouse models of depression suggest that changes in liver
metabolism might be involved in the pathogenesis of MDD. Conjoint analyses of fecal, serum, liver, and hippocampal
metabolites from fecal microbiota transplantation mice suggested that aminoacyl-tRNA biosynthesis significantly
changed and fecal metabolites showed a close relationship with the liver. These findings may help determine the
biological mechanisms of depression and provide evidence about “depression microbes” impacting on liver
metabolism.
Introduction
Major depressive disorder (MDD) is a debilitating
mental disorder accounting for 12.3% of the global burden
of disease and affects up to 15% of the general popula-
tion1. Recent studies suggest that MDD is associated
with neurotrophic alterations2, an imbalance in the
hypothalamic–pituitary–adrenal axis3, and glutamine
neurotransmitter system dysfunction4. Most research on
depression focuses on changes to the brain, and few stu-
dies have examined the effects of liver metabolism on
depression.
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Accumulating evidence suggests that disruption of
gastrointestinal microbes is associated with the develop-
ment or exacerbation of mental disorders in humans, and
the microbe–gut–brain axis may play a key role in main-
taining brain health and stress responses5–7.
A mouse model of depression has been established
using fecal microbiota transplantation (FMT), in which
fecal matter from MDD patients is implanted into germ-
free mice8,9. The germ-free mouse, which is free from
bacterial contamination, has been widely used to investi-
gate interactions between the microbiota and host10.
The liver is the main organ for substrate and energy
metabolism and plays an important role in oxidative
stress, glycogen storage, and the synthesis of secretory
proteins. A previous study reported that liver diseases
were associated with depression and suicide attempts11.
Recently, metabolomics has been used to define meta-
bolic disorders and specific biomarkers of various disease
states12,13. We have applied metabolomics to the serum14,
urine15, and peripheral blood mononuclear cells16 of
MDD patients, and the prefrontal cortex of a lipopoly-
saccharide (LPS)-induced mouse model of depression17.
During these studies, we identified five metabolites in
urine from MDD patients uniquely produced by bacteria
in the intestinal tract that were significantly decreased
relative to healthy controls (CONs). Of note, some clinical
studies have reported that MDD induced a relatively high
incidence of irritable bowel syndrome, a disease involving
gut microbe disorders15,18. It is possible that MDD has an
association with intestinal microbe dysbiosis. Further, we
analyzed fecal, serum, and hippocampal samples from a
depression microbe-induced mouse model, and found
that the metabolites might be associated with carbohy-
drate, amino acid, and nucleotide metabolism9. Based on
these findings, we considered “depression microbes” can
affects metabolism in the gut tract and serum. Whether
microbiota dysbiosis impacts on the liver metabolism
profile and whether the liver plays an important role in
the microbe–gut–brain axis are not clear.
With diverse methodologies, the combination of dif-
ferent metabolomics platforms can identify more synth-
esis metabolites than a single method19–21. In the current
study, three metabolomics approaches using nuclear
magnetic resonance (NMR), gas chromatography–mass
spectrometry (GC–MS), and liquid chromatography–mass
spectrometry (LC–MS) were combined to determine




Animal experiments were approved by the Third
Military Medical University (Chongqing, China) and the
Ethical Committee of Chongqing Medical University
(Chongqing, China). Kunming (germ-free) mice were
obtained from the Experimental Animal Research Center
at the Third Military Medical University and were kept in
flexible film gnotobiotic isolators until 6 weeks old and
weighing 30–40 g. Mice were housed in standard auto-
claved polypropylene cages with access to food and water
ad libitum under a 12-h dark–light cycle (light from 08:00
AM until 08:00 PM), and at a constant temperature (23±
1 °C) and relative humidity (50± 5%). Mice acclimatized
for 2 weeks to standard experimental conditions prior to
the commencement of experiments.
FMT and sample collection
MDD patients were diagnosed following a structured
psychiatric interview using DSM-IV-TR criteria and 17
items from the Hamilton depression rating scale. The
FMT was carried out via randomly selecting 0.5 g of
feces from five MDD or healthy individuals under an
oxygen-free environment, and all 0.5 g samples were
mixed in 7.5 mL of 0.9% saline to obtain suspension. Then
the microbiota was transplanted into germ-free mice in a
flexible film gnotobiotic isolator. After 2 weeks, behavioral
tests were performed. On completion of behavioral tests,
the livers of mice were immediately collected and stored
at −80 °C until metabolism analysis.
Gas chromatography–mass spectrometry
Twenty-four mouse livers (12 MDD and 12 CON) were
prepared for GC–MS metabolomics analysis. Briefly, a
100-mg liver sample was derivatized with pyridine
hydrochloride solution and N,O-bis(trimethylsilyl)tri-
fluoroacetamide (including 1% trimethylchlorosilane)
before undergoing GC–MS analysis. Full details for
derivatization and GC–MS conditions have been repor-
ted19. Analysis used the exported NetCDF file format
and TagFinder. As an internal standard, L-2-
chlorophenylalanine (0.03 mg/mL; methanol configura-
tion) was used to normalize peak areas of extracted ions.
Nuclear magnetic resonance
Liver tissue (~ 100mg) was mixed with 800 µL
methanol–water (4:1, v/v) before being homogenized,
ultrasonic extraction for 5 min, stewing for 20 min at 4 °C,
and centrifugation at 14,000 g for 10min at 4 °C. Super-
natant (200 µL) was transferred to a glass bottle for rapid
centrifugal concentrator volatile drying before being dis-
solved in 500 µL heavy water in a NMR tube prior to
detection.
Proton spectra were detected using a Varian 600 spec-
trometer at an operating power of 599.925MHz in 1H. A
Carr–Purcell–Meiboom–Gill (recycle delay−90°−(τ−180°
−τ)n−acquisition) pulse sequencer with a relaxation
delay of 2.5 s, a mixing time of 100m/s, a spectral width of
10 kHz, and a data point of 16 K was used cumulatively
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128 times. Discrimination between MDD and CON mice
was visualized using partial least-squares discriminant
analysis. Coefficient loading plots of the model were used
to identify the spectral variables responsible for the
sample differentiation on the score plot. A correlation
coefficient of │r│> 0.553 based on a p-level< 0.05 or
variable importance in projection (VIP) value > 1.000 was
used as the cutoff value for statistical significance.
Liquid chromatography–mass spectrometry
LC–MS preparation was performed as previously
described9. Briefly, 100 mg of liver sample was homo-
genized with 20 µL internal standard (l-2-chloro-L-phe-
nylalanine, 0.03 mg/mL; methanol configuration) and 800
µL methanol–water solution (4/1, v/v) before ultrasonic
extraction for 5 min, incubation for 20min at 4 °C, and
centrifugation for 10 min at 14,000 g at 4 °C. Supernatant
(200 µL) was transferred into a glass bottle for LC–MS
metabolomics analysis. Supernatant underwent ultra-
performance liquid chromatography–tandem mass spec-
trometry (UPLC-Q-TOF/MS). Mass spectrometric data
were collected using a Waters VION IMS Q-TOF mass
spectrometer equipped with an electrospray ionization
source operating in either positive or negative ion mode.
Full details are provided in a previous study9. Orthogonal
partial least-squares discriminant analysis (OPLS-DA)
was used to identify differential metabolites in MDD mice
compared with CON mice.
Metabolomics function and pathway analyses
For significantly altered metabolites (p< 0.05 and VIP
> 1.0), pathway analyses was performed using MetaboA-
nalyst 3.0 (http://www.metaboanalyst.ca/) and Ingenuity
pathway analysis (IPA) software. MetaboAnalyst is a
comprehensive web application for metabolomics
data analysis and interpretation. Metabolomics pathway
analysis used several databases, including the Human
Metabolome Database (HMDB; http://www.hmdb.ca/),
Metlin (https://metlin.scripps.edu/), and the Kyoto
Encyclopedia of Genes and Genomes (KEGG; http://www.
genome.jp/kegg/), and the MetaboAnalyst tool, which can
identify the most significantly changed metabolism
pathways.
Molecular network analysis
Previous studies applying proteomics and metabo-
nomics to the livers of chronic unpredictive mild stress
(CUMS) mouse models of depression reported disturbed
lipid metabolism and immune regulation22,23. In the
current study, we cross-analyzed the two mouse models
of depression using IPA. IPA is an advanced bioinfor-
matics software program used to analyze biological
pathways and functions of biomolecules of interest. The
higher the score, the more relevant the molecules are to
the network. The score is calculated using the right-tailed




Results of the behavioral tests are reported in our pre-
vious research9. Briefly, immobility times for the forced
swimming test and the tail suspension test significantly
increased and the center motion distance for the open-
field test significantly decreased in “depression microbes”
mice compared with “healthy microbes” mice, only
behavioral significant changes mice used for further
analysis. Using FMT, we constructed a mouse model of
depression.
Metabolites showing a significant difference between
MDD and CON mice
Metabolites from 12 MDD and 12 CON mice were used
for OPLS-DA analysis. OPLS-DA score plots showed
distinct separation between MDD mice and CON mice
using the three metabolomics approaches (LC–MS_pos:
R2Y= 0.868, Q2= 0.683; LC–MS_neg:R2Y= 0.798, Q2
= 0.618; GC–MS: R2Y= 0.549, Q2=−0.694; NMR: R2Y
cum= 0.936, Q2= 0.917) (Fig. 1). R2Y is the cumulative
model variation in Y, and Q2 is the cumulative predicted
variation. Values for these parameters approaching
1.0 indicate a stable model with predictive reliability.
In the current study, R2Y and Q2 values indicated
significant metabolic differences between MDD and
CON mice. The original total ion chromatograms,
typical base peak intensity chromatograms, and 1H
Carr–Purcell–Meiboom–Gill NMR spectra are shown in
Supplementary Fig. 1. A 199-iteration permutation test
confirmed that OPLS-DA models were not over-fitted and
were valid (Supplementary Fig. 2).
From OPLS-DA analysis, a total of 191 significantly
different metabolites were identified between the MDD
and CON mice using the three metabolomics approaches
(106 decreased and 85 increased in the livers of
MDD mice compared with CON mice). Details of the
metabolites are shown in Table 1 and Supplementary
Table 1.
Classification of the significantly changed metabolites
Using HMDB and MID for classification of metabolites
according to their super class revealed that many belon-
ged to the Lipid super class (linolenic acid, oxoproline,
maltotriitol, arachidonic acid, 13-hydroxy-docosanoic
acid) and the Amino acids, peptides and analogs super
class (alanine, isoleucine, glutamine, valine, iminodiacetic
acid), as well as Carbohydrates and Carbohydrate Con-
jugates (glycogen, glutathione, D-arabitol), Aliphatic
Acyclic Compounds (ethanolamine, trimethylamine
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N-oxide, phosphocholine, urea) among others. A part of
metabolites were clustering analyzed and emerged sig-
nificantly different trends, especially in the Lipid super
class (Fig. 2a). Lipid proportion >65% and Amino acids
nearly 10% in all metabolites, the number of each class
showed in Fig. 2b.
Metabolites analyzed between FMT and CON mice
The differential metabolites and their respective fold-
change were analyzed using MetaboAnalyst, KEGG, and
IPA to explore the potential effects of depression
microbes. We identified nine pathways with a p-value<
0.05 that were different in MDD mice compared with
Fig. 1 Orthogonal partial least-squares discriminant analysis (OPLS-DA) score plots and 1H nuclear magnetic resonance (NMR)
corresponding coefficient loading plots. a–c OPLS-DA score plots derived from ultra-performance liquid chromatography–tandem mass
spectrometry (UPLC-Q-TOF/MS) electrospray ionization (ESI) (+), UPLC-Q-TOF/MS ESI (−), and gas chromatography–mass spectrometry (GC–MS)
spectra of the major depressive disorder (MDD) group and control (CON) group. d OPLS-DA score plots derived from 1H Carr–Purcell–Meiboom–Gill
NMR spectra of liver extracts and corresponding coefficient loading plots e, f obtained from the CON group and the MDD group. e, f Show the
significance of metabolite variations between the two classes. Peaks in the positive direction indicate metabolites that are more abundant in MDD.
Metabolites more abundant in the CON group are shown as peaks in the negative direction. The key to assignment is shown in Supplementary Fig. 1
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Table 1 Metabolites identified in livers extracts
Metabolite/super class VIPa FC rb HMDB Platform P-valuec Trendd
Aliphatic acyclic compounds
Ethanolamine 2.60 – – HMDB00149 NMR – ↓
Trimetlylamine oxide 2.63 – – HMDB00925 NMR – ↓
Phosphocholine 1.89 – – HMDB01565 NMR – ↑
Urea 3.85 1.76 – HMDB00294 GC–MS 0.04 ↑
Putrescine 1.16 1.25 – HMDB01414 GC–MS 0.03 ↑
Amino acids, peptides, and analogs
Alanine 1.46 – – HMDB00161 NMR – ↑
Glycine 1.08 – – HMDB00123 NMR – ↑
Glycerol 1.79 – 0.64 HMDB00125 NMR – ↑
Hypoxanthine – – 0.68 HMDB00157 NMR – ↑
Histidine – – −0.90 HMDB00177 NMR – ↓
Lysine 1.56 – – HMDB00182 NMR – ↑
Phosphocreatine – – 0.59 HMDB01511 NMR – ↑
Iminodiacetate 36.22 – −0.98 HMDB11753 NMR – ↓
Alanine 5.44 1.24 – HMDB00161 GC–MS 0.00 ↑
Proline 3.20 1.25 – HMDB00162 GC–MS 0.01 ↑
Isoleucine 2.93 1.45 – HMDB00172 GC–MS 0.01 ↑
Glutamine 3.01 0.46 – HMDB00641 GC–MS 0.00 ↓
Valine 3.80 1.39 – HMDB00883 GC–MS 0.02 ↑
3-Aminoisobutyric acid 4.22 3.21 – HMDB03911 GC–MS 0.00 ↑
Carbohydrates and carbohydrate conjugates
Glycogen 2.74 – – HMDB00131 NMR – ↑
β-Glucose 1.92 – – HMDB00516 NMR – ↓
Glutathione – – 0.58 HMDB00757 NMR – ↑
α-Glucose 3.55 – −0.68 HMDB03345 NMR – ↓
D-Arabitol 1.27 2.19 – HMDB00568 GC–MS 0.00 ↑
Galactinol 14.68 0.59 – HMDB05826 GC–MS 0.00 ↓
Nucleosides, Nucleotides, and Analogs
Inosine – – 0.58 HMDB00195 NMR – ↑
Uridine diphosphate–glucose – – 0.71 HMDB00286 NMR – ↑
Uridine – – 0.61 HMDB00296 NMR – ↑
Lipids
Linolenic acid 1.29 1.44 – HMDB01388 GC–MS 0.03 ↑
Oxoproline 6.14 1.35 – HMDB08177 GC–MS 0.00 ↑
Maltotriitol 6.15 0.64 – HMDB15224 GC–MS 0.00 ↓
Organic acids and derivatives
Lactate 2.42 – – HMDB62492 NMR – ↑
3-Hydroxybutyrate – – 0.63 HMDB00357 NMR – ↑
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CON mice (Supplementary Table 2). After p-values were
adjusted using Holm–Bonferroni corrections and the false
discovery rate, only glycerophospholipid metabolism sig-
nificantly changed. Canonical pathway overlapping ana-
lyzed using IPA (Supplementary Fig. 3) included tRNA
charging, glutamate receptor signaling. A total of 16
metabolites were identified as being significantly asso-
ciated with glycolysis and the tricarboxylic acid cycle (Fig.
2c).
System integrated analysis in FMT mice
From system integrated analysis of significant metabo-
lites in the feces, serum and hippocampal samples iden-
tified in a previous study9, the amino acids asparagine,
glutamine, isoleucine, proline, leucine, and glycine, which
are involved in aminoacyl-tRNA biosynthesis, were most
significantly altered. Details of the KEGG pathways are
shown in Fig. 3a.
We also compared overlapping metabolites in different
regions of FMT mice (Fig. 3b), and found that nine
metabolites in the feces had a close association with the
liver, and are mainly involved in energy and lipid meta-
bolism (Supplementary Fig. 4).
Combined analysis of FMT and CUMS mice
Metabolites showing significant changes detected by
LC–MS in livers from FMT and CUMS mice with mini-
mum overlapping are listed in Fig. 3c. In super class,
mainly of the metabolites belong to lipid. We analyzed
metabolic pathways and glycerophospholipid metabolism
was disturbed in FMT mice. Interesting to note that
CUMS mice had the same change.
Glycerophospholipid is usually subdivided into phos-
phatidylethanolamine (PE), phosphatidylcholine (PC),
phosphatidic acid (PA), and phosphoinositides (PS). PC
species not only protects cells and their organelles from
oxidative stress, but also is an essential component of
biomembranes. PE species has been identified as mod-
ulator of inflammation24. The disturbance of glycer-
ophospholipid metabolism indicated oxidative stress,
inflammatory cell membrane damage, and even apoptosis
in the liver during FMT and CUMS. The common path-
way disturbance in liver may play an important role in
depression.
Molecular network analysis of FMT mice using IPA
A total of 191 metabolites and their respective fold-
changes were subjected to molecular interaction network
analysis using IPA software. Lipid Metabolism, Small
Molecule Biochemistry, and Cellular Compromise were
the most significantly changed network. A total of 21
metabolites, including L-glutamine, linolenic acid, lysine,
phosphorylcholine, urea, L-proline, and glycogen, were
associated with the network (Fig. 4).
Molecular network analysis of FMT and CUMS mice by IPA
In a study that undertook quantitative proteomics
analysis of livers from the CUMS mouse model of
depression, a total of 66 proteins were reported to exhibit
significantly different expression22.
We combined proteomics and metabolomics using IPA
to examine the two models of depression, which showed
behavioral changes stemming from different mechanisms.
The Lipid Metabolism, Free Radical Scavenging and
Table 1 continued
Metabolite/super class VIPa FC rb HMDB Platform P-valuec Trendd
Lactic acid 3.00 1.14 – HMDB00190 GC–MS 0.01 ↑
Succinic acid 1.56 1.68 – HMDB00254 GC–MS 0.00 ↑
Organophosphorus compounds
O-phosphorylethanolamine 1.09 0.31 – HMDB00224 GC–MS 0.01 ↓
Phosphomycin 1.85 0.49 – HMDB14966 GC–MS 0.00 ↓
Others/unknown
Uracil – – −0.56 HMDB00300 NMR – ↓
Hypoxanthine 3.58 1.29 – HMDB00157 GC–MS 0.00 ↑
Xanthine 2.79 1.27 HMDB00292 GC–MS 0.00 ↑
D-(glycerol 1-phosphate) 1.81 0.38 – HMDB00126 GC–MS 0.01 ↓
VIP variable importance in projection, FC fold change, HMDB Human Metabolome Database. All identified metabolites were grouped by super class (based on HMDB
website information)
1 A VIP value > 1.000 was used as the cutoff value for statistical significance. “-” means the correlation coefficient of │r│ < 0.553 or VIP value of <1.000
2 Correlation coefficients: positive and negative signs indicate a positive or negative correlation in the concentrations. A correlation coefficient of │r│ > 0.553 was
used as the cutoff value for statistical significance based on discrimination significance at a p-level of 0.05 and 11 degrees of freedom (df)
3 p-Value was derived from two-tailed Student’s t-test
d “↑” indicates higher levels in major depressive disorder (MDD), and “↓” indicates lower levels in MDD
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Molecule Transports network had a high score of 99, and
included high-density lipoprotein, low-density lipopro-
tein, the nuclear factor κB signaling pathway (Supple-
mentary Fig. 5). From canonical pathway analysis, we
found that the overlap centered on Glycogen degradation
and Tryptophan Degradation (Supplementary Fig. 6).
Discussion
Depression is a widespread and debilitating mental
disorder that contributes to increased suicide rates and
has a heavy socioeconomic burden; however, little is
known about its pathogenesis. The gut microbiota is the
largest ecosystem in the body and affects numerous
physiological functions. The microbe–gut–brain axis is a
communication system that integrates neural, hormonal,
and immunological signals and metabolites between the
gut and the brain25. Bacterial products, including lactic
acid, organic acids, tryptophan, and propionic acid, have
been shown to influence behavior in animals26, con-
jugated fatty acids, LPS, peptidoglycan, acylglycerols,
sphingomyelin, and cholesterol can affect intestinal per-
meability and activate the intestine–brain–liver–neural
axis to regulate glucose homeostasis27.
Research on depression usually focuses on the central
nervous system and peripheral nervous system, rather
than the liver. To the best of the authors’ knowledge, this
is the first study to apply untargeted metabolomics
approaches to the liver of a FMT mouse model of
depression.
Liver has a unique vascular system and its blood mainly
comes from intestine through the portal vein28. Due to
the system, liver is vulnerable to exposure to bacterial
products. Despite profound interindividual variability,
Gram-negative bacteria, such as Bacteroidetes,
Fig. 2 Data on significant metabolites and energy metabolism. a Clustering analysis different metabolites in the liver (major depressive disorder
(MDD) group vs. the control (CON) group). b Number of metabolites identified using the three complementary approaches in each super class. A
total of 191 metabolites were identified using gas chromatography–mass spectrometry (GC–MS) (blue), nuclear magnetic resonance (NMR) (red),
liquid chromatography–mass spectrometry (LC–MS) (green), or combined approaches (purple), and super classification was performed. c Summary of
the differential metabolites associated with glycolysis and the tricarboxylic acid (TCA) cycle
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Enterobacteriaceae, Alistipes, and Proteobacteria were
strongly increased in MDD patients compared with the
healthy individuals29. Furthermore, increased LPS from
Gram-negative bacteria induced endothelial hyperper-
meability and “leaky gut” in MDD patients30,31. The “leaky
gut” increased translocation of gut-derived bacterial pro-
ducts and then stimulated innate immune system, which
may involve in the pathophysiology of MDD32. In this
study, FMT from MDD patients may change gut perme-
ability, hence, liver was exposed to bacterial products and
presented disturbed metabolism profile.
In this study, we used three complementary techniques
in our untargeted metabolomics approach, these being
GC–MS, NMR, and LC–MS. Using these techniques, 191
differential metabolites were distinguished between mice
livers treated with “depression microbes” and “healthy
microbes”. Importantly, just one metabolite (alanine) was
identified by two approaches. The application of com-
plementary approaches to metabolomics for the char-
acterization of liver metabolism is of value. The
metabolites identified included: (1) lipids (5-oxoproline
and linolenic acid) and lipid metabolism-related mole-
cules (α-glucose, β-glucose, and glycerol); (2) amino acids
(glycine, proline, valine, isoleucine, lysine, and histidine);
and (3) other metabolites (O-phosphorylethanolamine,
putrescine, and trimethylamine N-oxide).
The amino acids, including glutamine, glycine, lysine,
valine, and isoleucine, which had significantly changed in
the mouse model of depression compared with CON
mice. Some of these amino acids have an important role
in brain function. Glutamine is a neurotransmitter that
plays a crucial role in glutamatergic neurotransmission
through contact with astrocytes and neurons in the
glutamine–glutamate cycle33. Preclinical research has
reported that glutamine deficiency in the prefrontal cortex
and cerebellum increased depressive-like behavior34,35.
We found that glutamine significantly decreased in per-
ipheral blood mononuclear cells and the cerebellum of
the mouse model of depression, suggesting that it could
be a potential biomarker of depression35–37. We also
Fig. 3 Metabolite cross-talk in different regions and chronic unpredictive mild stress (CUMS) mouse model of depression. a Construction of
the aminoacyl-tRNA biosynthesis metabolism pathway in mice. The map was generated using the reference map from Kyoto Encyclopedia of Genes
and Genomes (KEGG) (http://www.genome.jp/kegg/). Green boxes show enzymatic activities. b Venn diagram indicating the number of significant
metabolites in different parts of major depressive disorder (MDD) mice. c Venn diagram indicating the number of significant metabolites in the livers
of the fecal microbiota transplantation (FMT) and CUMS mice models of depression. A common metabolite was hypoxanthine
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conducted metagenomics using murine cecum feces from
the same batch samples in this study, and relative abun-
dance of the glutamate biosynthesis enzyme commission
numbers showed a contrary trend9. The decrease in glu-
tamine may suggest that microbes can affect liver gluta-
mate levels and may modulate depressive-like behavior.
The lysine level increased in MDD mice compared with
CON mice. Recent studies report that lysine may affect
neurotransmitters associated with anxiety and stress in
the rat38, whereas lysine fortification reduces anxiety and
lessens stress in humans39. Lysine is a constituent of the
serotonin receptor 4 antagonist, which can reduce the
level of blood cortisol and the microbe–gut–brain stress
response in pigs40. In previous studies, we found that
lysine levels decreased in the serum of MDD patients41,
and in the cerebellum and prefrontal cortex of CUMS
mice35,42. Accordingly, increasing lysine may combat
depressive behavior and improve a person’s emotional
status.
Metabolism research reports that valine levels decrease
in peripheral blood mononuclear cells and the serum of
drug-naïve MDD patients14,43. Similarly, alanine was
reported to decrease in the serum of MDD patients, and
may be a potential urine biomarker for MDD patients44.
Fig. 4 The most significantly changed network between major depressive disorder (MDD) and control (CON) groups. Metabolites in red
were upregulated while those in green were downregulated in MDD mice. Solid lines show direct physical interactions (such as binding) between
the two parties. Dotted lines show indirect interactions or regulations between the two parties
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In the current study, valine, isoleucine, and alanine
increased in MDD mice liver. Levels of the three amino
acids showed no difference among the serum, hippo-
campus, and feces9. These results suggest that MDD
patients and FMT mice accompanied amino-acid meta-
bolism disturbed and the trends were not exactly same in
different parts. The liver is the center for substrate and
energy metabolism. Glucose is an important energy pro-
vider, and in the current study, it was found to be
decreased in MDD mice compared with CON mice.
Other metabolites involved in glycolysis and the tri-
carboxylic acid cycle were markedly downregulated, such
as lactic acid (Fig. 4). Combined IPA and canonical
pathway analysis revealed glycogen degradation. These
changes indicate a disturbance in energy metabolism. In
agreement with previous research, a deficiency in circu-
lating glucose was observed with serum and urine meta-
bolomics studies of MDD patients14,44. Also, levels of
glucose were markedly decreased in the prefrontal cortex
of LPS-induced mice17. Blass et al. reported two clinical
cases in which patients with symptoms of depression
showed significant improvement in mood after 2 weeks
administration of supplemental malic acid and glucose45.
Zheng et al. conducted a metabolomics analysis of feces
and serum using the same FMT mouse model of
depression and found increased levels of carbohydrate
metabolites in MDD mice9. Combining previous results
with the results of the current study suggest that
“depression microbes” may lead to a glucose disorder in
liver. As the brain consumes 25% of the total glucose
available in the body, the decrease in liver glucose may
result in depressive behavior.
Phosphocreatine is a high-energy phosphate compound
abundant in the central nervous system and functions as a
transporter in cell energy exchange. It can transfer high-
energy phosphate to ADP to provide ATP, generating
creatine. Creatinine is a non-enzymatic by-product of
creatine and phosphocreatine. In the current study,
phosphocreatine showed a significant increase in the
livers of MDD mice compared with CON mice. Zheng
et al. reported that creatine in the serum of MDD patients
was significantly decreased14. We did not detect the sec-
ondary metabolite creatinine in the current study, but
metabolism research has reported that creatinine in the
urine of MDD patients and in the cerebellum of CUMS
mice decreased29,44. Upregulated phosphocreatine in the
liver may be a compensatory energy source, providing
beneficial help to improve depressive behavior.
The findings suggest that disturbances to glycolysis and
the tricarboxylic acid cycle and the phosphocreatine–ATP
pathway support previous research suggesting that a dis-
turbance in energy metabolism may participate in the
pathophysiology of depression, and the liver may play an
important role.
Disturbances to oxidative stress are reported to be
associated with the pathogenesis of MDD46. In the current
study, we found that the metabolites glycine and glu-
tathione were significantly upregulated in MDD mice.
These metabolites are involved in oxidative stress. As
glutathione is the primary free radical scavenger in the
brain, lower glutathione levels compromise central ner-
vous system anti-oxidative activity47. Additionally, lower
levels of glutathione and oxidative damage could con-
stitute early signaling events in cell apoptosis48. Glycine
has been suggested to be a member of glutathione bio-
synthesis. In our previous metabolism research using the
same FMT mouse model of depression, we found that
glutathione levels decreased in the prefrontal cortex and
the cecum, and glycine decreased in the hippocampus9.
The metabolites in different parts may show different
trends in diseased conditions. The elevated levels of glu-
tathione in the liver suggest increased anti-oxidation
activity, which may provide protection from oxidative
stress in MDD mice.
Disturbances in lipid metabolism have been reported to
be associated with geriatric depression in elderly
patients49 and in rodent models of depression50. In the
current study, lipid-related molecules (a total of 126; 66%
of all metabolites) showed a tendency to change in the
livers of MDD mice. These molecules included O-phos-
phorylethanolamine, glycerol, and arachidonic acid.
Glycerol is the final product of triglyceride metabolism.
These findings suggest that MDD mice may have lipid
metabolism dysregulation. Combined proteomics of
CUMS mice livers showed a high score for the Lipid
Metabolism, Free Radical Scavenging and Molecule
Transports network. Furthermore, common fecal and
liver metabolites appeared to show disturbed lipid
metabolism. Disturbances in the metabolism of the three
major nutrients in the MDD liver may account for
the high comorbidity between MDD and metabolic
syndrome51.
This study has some limitations. The findings and
conclusions drawn need to be treated cautiously because
of the risk for overestimation with the relatively small
sample size. Second, we did not validate quantities and
species of microbes. The potential mechanism behind the
association between microbes and liver metabolism dis-
turbance is unclear. Further, data were obtained from
naive mice, additional studies should use an adult animal
model of depression and conduct in vitro studies. Finally,
we integrated information about metabolites trends from
different depressive models, organs, and regions as far as
possible. However, the potential relationships are not
clear and need further research. In future study, we will
focus on the mechanism of single strains inducing liver
metabolism disturbance and the relationship between gut
microbiota and depression.
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Conclusion
In this study, we developed and analyzed a FMT mouse
model of depression, and the findings contribute to pre-
vious studies on the involvement of the gut microbiota in
psychiatric disorders. Using GC–MS, NMR, and LC–MS,
we identified 191 changed metabolites in the MDD mouse
liver compared with CON mice. The study mainly focused
on three major disturbances in metabolism, these being
associated with lipid, amino acid, and energy metabolism.
Combined analyses with proteomics of CUMS mice livers
showed a changed lipid network, suggestive of lipid dis-
orders in the livers of mouse models of depression.
Conjoint analyses of metabolites in different parts of the
FMT model suggested that aminoacyl-tRNA biosynthesis
significantly changed and metabolites in feces were
most closely associated with the liver. The findings sug-
gest that “depression microbes” can disturb the liver and
different parts of the body carrying out metabolic func-
tions, and help determine the relationship between the
liver, microbes, and depression. It is possible that treat-
ment targeting microbes may be potential therapies for
MDD.
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